Colin Davidson has previously received funding from the NIH (USA) and the European Community for projects related to drug abuse. His PhD, on the SSRI paroxetine, was sponsored by GSK. He is currently a consultant on psychoactive substances for the UK Defence Science Technology Labs and is a member of the Advisory Council on the Misuse of Drugs (UK). The views expressed here are his own.
Italics are mine. So the only reason this dude is a PhD is because a pharmaceutical company bought and paid for it. Seems less than honest to me.
Horrible medical journalism.
And yes, I see the authors credentials.
Colin Davidson has previously received funding from the NIH (USA) and the European Community for projects related to drug abuse. His PhD, on the SSRI paroxetine, was sponsored by GSK. He is currently a consultant on psychoactive substances for the UK Defence Science Technology Labs and is a member of the Advisory Council on the Misuse of Drugs (UK). The views expressed here are his own.
Italics are mine. So the only reason this dude is a PhD is because a pharmaceutical company bought and paid for it. Seems less than honest to me.